NEW YORK (GenomeWeb News) – Exosome Diagnostics today said that Promega will be the exclusive supplier of its Urine Clinical Sample Concentrator Kit, which incorporates Exosome's technology for concentration of urinary exosomes.

The kit is sued for molecular diagnostic applications, and New York-based Exosome said that it will be used to process urine samples for clinical trials in genitourinary disorders, such as prostate cancer. Financial and other terms of the agreement weren't disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.